Hims
Hims & Hers Health Addresses Scrutiny of GLP-1 Composition | STATUS
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy, with a focus on the impacts of digital healthcare for patients, providers, and businesses. You can reach Katie on Signal at palmer.01. Over the past year and a half, direct-to-consumer telehealth company Hims & Hers has become a leading voice in the debate […]
2 mins read
Hims & Hers Won’t Sell Compound Version of Novo’s Obesity Pill
Hims & Hers announced Saturday that it would stop selling what it claims is a cheaper, compounded version of Novo Nordisk’s obesity pill on its telehealth platform, after health officials called for an investigation into the company for potential violations of federal law. Hims launched the compounded drug earlier this week at $49 per month. […]
1 min read